Protein A Resin Market, By Product (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based), By Application (Immunoprecipitation (IP), Antibody Purification), By End User (Biopharmaceutical M

Protein A Resin Market, By Product (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based), By Application (Immunoprecipitation (IP), Antibody Purification), By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Protein A is a bacterial protein, which has capacity to bind mammalian antibodies of class immunoglobulin G with great affinity. Protein G binds to all subclasses of human immunoglobulin G (IgG) makes it useful for purifying polyclonal or monoclonal IgG antibodies whose subclasses have not been determined. Monoclonal antibodies are defined as ‘an antibody produced by a single clone of cells'. It can be used to carry drugs, toxins, or radioactive substances traditional to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis. These are essential and are broadly used as purification and separation materials due to high resolution, across the biopharmaceutical industry. Natural protein A can be produced from Staphylococcus aureus, though protein A is now commonly produced recombinant in Escherichia coli. Chromatography with these has several advantages as a separation method, over conventional techniques such as solvent extraction, crystallization, and distillation.
Restraints of the Global Protein A Resin Market
Major factors hampering the growth of the protein A resin market during the forecast period constitutes of rise in alternate methods for purification of monoclonal antibodies.
Key features of the study:
This report provides in-depth analysis of the global protein A resin market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global protein A resin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global protein A resin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Protein A Resin Market, By Product:
Natural Protein A
Recombinant Protein A
Global Protein A Resin Market, By Matrix Type:
Agarose-based
Glass or Silica Based
Organic Polymer Based
Global Protein A Resin Market, By Application:
Immunoprecipitation (IP)
Antibody Purification
Global Protein A Resin Market, By End User:
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
Global Protein A Resin Market, By Geography:
North America
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country:
U.S.
Canada
Europe
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product
Natural Protein A
Recombinant Protein A
By Matrix Type
Agarose-based
Glass or Silica Based
Organic Polymer Based
By Application
Immunoprecipitation (IP)
Antibody Purification
By End User
Biopharmaceutical Manufacturers
Clinical Research Laboratories
Academic Institutes
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
GE Healthcare*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific
Repligen
Tosoh Bioscience
EMD Millipore
Novasep
GenScript Biotech Corporation
Purolite Life Sciences
Expedeon Ltd.
Other Players
“*” marked represents similar segmentation in other categories in the respective section.